In a follow-up study called ASSURANCE, people completed questionnaires, and those currently taking AVONEX for up to 15 years reported better overall results in key areas compared with people with MS not currently taking AVONEX.

* Based on a 2-year study and patient-reported follow-up at 15 years. FDA-approved labelling includes up to 3 years of clinical data.